New Horizons Session
NH 13 - New CT developments in oncologic imaging
Lectures
1
Chairperson's introduction
05:00Giovanni Cappello, Candiolo / IT
2
Photon-counting CT in oncology
15:00Elige Karam, Paris / FR
3
CT perfusion in oncology: a new standard in cancer imaging
15:00Murali Krishna Logudoss, Chennai / IN
4
CT radiomics in oncology: what are the most robust biomarkers?
15:00Luis Marti-Bonmati, València / ES
5
Artificial intelligence (AI) applications in conventional CT for oncologic imaging
15:00Lukas Müller, Mainz / DE
6
Panel discussion: Will CT evaluation keep its dominance in oncologic imaging?
25:00Panel discussion: Will CT evaluation keep its dominance in oncologic imaging?
This session will explore cutting-edge advancements in CT oncologic imaging. Experts will discuss the potential of photon-counting CT, the most reliable radiomic biomarkers, and the impact of artificial intelligence on conventional CT imaging. Attendees will gain a deeper understanding of how these innovations enhance precision in cancer imaging and patient care.
5 min
Chairperson's introduction
Giovanni Cappello, Candiolo / Italy
15 min
Photon-counting CT in oncology
Elige Karam, Paris / France
15 min
CT perfusion in oncology: a new standard in cancer imaging
Murali Krishna Logudoss, Chennai / India
15 min
CT radiomics in oncology: what are the most robust biomarkers?
Luis Marti-Bonmati, Valencia / Spain
15 min
Artificial intelligence (AI) applications in conventional CT for oncologic imaging
Lukas Müller, Mainz / Germany
25 min
Panel discussion: Will CT evaluation keep its dominance in oncologic imaging?